Valuation: Hofseth BioCare ASA

Market Cap 68Cr 7.39Cr 6.63Cr 6.13Cr 5.55Cr 10Cr 703.37Cr 10Cr 73Cr 29Cr 368.06Cr 28Cr 27Cr 1.17TCr P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 98Cr 11Cr 9.46Cr 8.75Cr 7.92Cr 15Cr 1TCr 15Cr 104.6Cr 42Cr 525.63Cr 40Cr 39Cr 1.67TCr EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
74.84%
Yield 2024 *
-
Yield 2025 -
1 week-1.50%
Current month-0.76%
1 month-4.73%
6 months+0.77%
Current year-0.76%
1 week 1.26
Extreme 1.265
1.4
1 month 1.25
Extreme 1.25
1.48
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.06
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.7
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 01/08/2022
Director of Finance/CFO - 01/09/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 55 01/05/2015
Director/Board Member - -
Director/Board Member - 03/12/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/07/23 Buy 74,000 0.0187%
28/02/23 Buy

Chief Technology Officer

2,00,000 0.0506%
17/02/23 Buy

Director

1,00,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.50%-35.15%-54.20% 7.33Cr
-0.53%-0.79%+4.35%-15.24% 26TCr
-0.87%-1.51%+2.63%-6.34% 7.96TCr
+2.63%+3.98%-18.99%+13.54% 4.42TCr
-1.60%-3.12%+25.27%+7.64% 3.77TCr
-0.83%-2.88%-9.58%-12.37% 3.31TCr
+0.37%-1.93%+19.84%+86.14% 3.09TCr
-2.96%-1.85%-13.56%-10.37% 2.96TCr
-0.79%+1.32%-6.70%-24.70% 2.85TCr
-0.69%+2.21%+4.67%+6.73% 2.74TCr
Average -0.53%-0.76%-2.72%-0.92% 5.69TCr
Weighted average by Cap. -0.53%-0.49%+2.24%-3.75%

Financials

2024 2025
Net sales 27Cr 2.87Cr 2.57Cr 2.38Cr 2.15Cr 4.02Cr 273.01Cr 4.07Cr 28Cr 11Cr 142.86Cr 11Cr 11Cr 453.53Cr 26Cr 2.77Cr 2.48Cr 2.3Cr 2.08Cr 3.88Cr 263.55Cr 3.93Cr 27Cr 11Cr 137.91Cr 10Cr 10Cr 437.82Cr
Net income -13Cr -1.35Cr -1.21Cr -1.12Cr -1.02Cr -1.9Cr -128.82Cr -1.92Cr -13Cr -5.34Cr -67Cr -5.08Cr -4.97Cr -214Cr -13Cr -1.46Cr -1.31Cr -1.21Cr -1.09Cr -2.04Cr -138.67Cr -2.07Cr -14Cr -5.75Cr -73Cr -5.46Cr -5.35Cr -230.37Cr
Net Debt 15Cr 1.57Cr 1.41Cr 1.3Cr 1.18Cr 2.2Cr 149.39Cr 2.23Cr 16Cr 6.2Cr 78Cr 5.89Cr 5.76Cr 248.17Cr 29Cr 3.16Cr 2.84Cr 2.62Cr 2.38Cr 4.44Cr 301.12Cr 4.49Cr 31Cr 12Cr 157.57Cr 12Cr 12Cr 500.23Cr
Projected Income Statement - Annual - Hofseth BioCare ASA
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
28/26/28 NOK 1.310 0.00% 0
27/26/27 NOK 1.310 -0.38% 44,422
26/26/26 NOK 1.315 -1.50% 1,17,785
23/26/23 NOK 1.335 -1.48% 62,248
22/26/22 NOK 1.355 +1.88% 49,626